HALO Growth 100 · Sector S2
Longevity & Healthspan
GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.
Equal-weight — 1d —
Cap-weighted — 1d —
Momentum (drift) — 1d —
Constituents — in this sector
Composite Index — since inception (Dec 30, 2025)
Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.
Constituents
Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.
| Ticker | Company | Region | Last | 1d | 1w | 1m | 3m | 6m | 1y | CCY |
|---|---|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron | NAM | 834.04 | +0.90% | +3.80% | +27.94% | +29.79% | +6.97% | +41.47% | USD |
| NTRA | Natera | NAM | 332.03 | +2.21% | +7.13% | +25.44% | +63.01% | +56.53% | +106.69% | USD |
| AMGN | Amgen | NAM | 439.33 | +1.29% | +5.81% | +18.26% | +30.20% | +17.23% | +51.51% | USD |
| VRTX | Vertex Pharma | NAM | 548.05 | +1.44% | +8.36% | +15.84% | +26.41% | +14.92% | +38.97% | USD |
| ILMN | Illumina | NAM | 219.40 | +2.89% | +14.94% | +11.45% | +51.49% | +86.45% | +117.66% | USD |
| ZEAL.CO | Zealand Pharma | EUR | 321.20 | +2.10% | +0.00% | +8.18% | +1.01% | -17.22% | -18.68% | DKK |
| LLY | Eli Lilly | NAM | 1255.40 | +0.88% | +6.38% | +5.86% | +20.52% | +24.36% | +78.52% | USD |
| GXI.DE | Gerresheimer | EUR | 27.60 | +1.40% | +1.62% | +4.07% | +0.80% | +44.20% | -40.00% | EUR |
| NVO | Novo Nordisk | EUR | 46.74 | +1.30% | +1.85% | -2.99% | +5.29% | +2.18% | -10.77% | USD |
| VKTX | Viking Therapeutics | NAM | 33.89 | -1.37% | +2.11% | -4.24% | +10.46% | +9.22% | +31.92% | USD |